Cutting Through Confusion: Multimodality Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

J Oncol Pract. 2016 Oct;12(10):924-925. doi: 10.1200/JOP.2016.016923.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adenocarcinoma
  • Combined Modality Therapy
  • Humans
  • Neoadjuvant Therapy*
  • Pancreatic Neoplasms*